Before the 1990s, global health policy had a visibility problem. Governments and international institutions made decisions based almost entirely on mortality statistics – how many people died, and from what. If a disease didn’t kill you, it barely counted. This meant that conditions like depression, anxiety, and schizophrenia – which rarely appear on death certificates but rob millions of people of functional, healthy years – were effectively invisible to policymakers. The Global Burden of Disease (GBD) study changed that. What started as a single commissioned report has grown into one of the most consequential research enterprises in the history of public health.
Table of Contents
Origins of the GBD study
The story begins in the early 1990s, when the World Bank was preparing its first-ever policy report on health. The analysts began work in 1991, asking two straightforward questions: what are the most important causes of death in the world, and what causes the most ill-health? The problem was that no coherent, internally consistent answer existed. As Christopher Murray, one of the study’s founders, has described it, if you added up all the health claims circulating at the time, the figures would have implied the world’s population was dying three times over.
The original GBD study was commissioned in 1992 by the World Bank for its 1993 World Development Report on Investing in Health, and was carried out by Chris Murray at Harvard University and Alan Lopez at the World Health Organization, in collaboration with a global network of over 100 scientists. The goal was to build a comprehensive, systematic picture of health loss – one that treated every disease and injury on equal footing, regardless of whether it had a powerful advocacy lobby behind it.
This GBD study served as the most comprehensive effort up to that point to systematically measure the world’s health problems, generating estimates for 107 diseases and 483 sequelae – that is, nonfatal health consequences related to a disease. It covered eight regions and five age groups with estimates through 1990.
The results were genuinely surprising. The leading causes of disease burden in 1990 included childhood diseases, mental disorders, and road traffic accidents – categories that had barely registered in traditional mortality-based analyses. Mental health, which lacked any meaningful global advocacy at the time, was suddenly on the map.
From one study to a global consortium
The 1990 report was a one-time effort, but its impact was lasting. The GBD 1990 study had a profound impact on health policy and agenda-setting throughout the world, especially as it brought global attention to otherwise hidden or neglected health issues. It inspired further iterations, each more ambitious than the last. GBD 2010 brought together a community of nearly 500 experts from around the world in epidemiology, statistics, and other disciplines, and produced estimates for 291 diseases and injuries, 67 risk factors, and 1,160 sequelae across 21 regions and 187 countries. Today, the GBD has grown into an international consortium of over 17,000 researchers, with estimates updated annually.
Key metrics: DALYs and YLDs
One of the most enduring contributions of the original GBD study was a new way of measuring health loss. Before 1990, health was largely tracked through mortality – years of life lost to premature death. But this left out an entire dimension of suffering: the years people spend alive but disabled, in pain, or unable to function. To capture this, the GBD introduced the disability-adjusted life year (DALY).
One DALY represents the loss of the equivalent of one year of full health. DALYs for a disease or health condition are the sum of years of life lost due to premature mortality (YLLs) and years of healthy life lost due to disability (YLDs) due to prevalent cases of the disease or health condition in a population. In other words, the DALY formula is: DALY = YLL + YLD.
For mental health, the Years Lived with Disability (YLD) component is especially important. Conditions like depression and osteoarthritis are leading causes of DALYs not because they cause many deaths, but because they are the two leading causes of YLDs – conditions that do not typically appear among the leading causes of death or years of life lost. This distinction is critical: a person living with severe depression for 20 years accumulates significant YLDs even if the condition never directly shortens their life.
How disability weights work
Disability weights represent the severity of a disease and range from 0 (perfect health) to 1 (equivalent to death). These weights are applied to prevalence and duration data to calculate YLDs. A condition with a high disability weight that affects millions of people for many years – like severe depression or schizophrenia – will generate a large YLD burden even in the absence of direct mortality. This is precisely what makes YLDs the most revealing metric for understanding mental illness at a population level.
The global number of DALYs due to mental disorders increased from 80.8 million in 1990 to 125.3 million in 2019, and the proportion of global DALYs attributed to mental disorders increased from 3.1% in 1990 to 4.9% in 2019. These numbers would have been impossible to generate without the YLD framework – and they make the case for mental health investment in a language that health economists and policy-makers understand.
Why DALYs matter for mental health policy
Before the GBD introduced DALYs, mental health conditions were routinely deprioritized in national health budgets because they didn’t show up prominently in death statistics. The DALY metric corrected this distortion. Mental illness is now one of the leading diseases as measured by global burden of disease studies, with depression alone accounting for 51.84 million DALYs. This reframing has been consequential: countries have used their burden of disease results to establish policies on mental health, with some creating dedicated national institutes for mental health to develop solutions.
Regional and income-based insights
The GBD framework has also revealed significant disparities in how mental illness manifests – and how it is tracked – across different regions and income groups. The picture that emerges is one of large, systematic inequalities in both burden and response.
As per GBD 2021, mental and behavioral disorders account for approximately 7-8% of all DALYs and about one-fifth of YLDs worldwide. But this global average masks enormous variation. High-income countries have made significant advancements in the development of integrated and rights-based mental health systems, with robust legislation, better funding, and more specialists. In contrast, many LMICs struggle with outdated or fragmented policies, chronic workforce shortages, underfunding, and weak infrastructure.
The underreporting problem in LMICs
One of the most significant challenges in interpreting GBD data across income groups is underreporting in low- and middle-income settings. Underdeveloped mental health monitoring systems in LMICs often lead to dependencies on modeled data rather than real evidence, underreporting, and a lack of diagnostic coverage. When a country lacks psychiatrists, diagnostic infrastructure, or community awareness of mental illness, cases simply go unrecorded – meaning the GBD must rely on modeled estimates rather than direct measurement.
Cultural factors compound this problem. Diagnosis methods and surveys developed in the West may have limited utility in other cultures, where mental health conditions manifest differently. For example, patients in Sub-Saharan Africa who seek medical help for physical aches and pains are often found to be suffering from depression – yet this goes unrecognized. People engaged in manual labor may also be less likely to report cognitive symptoms like difficulty concentrating, which are standard diagnostic indicators for depression in Western clinical settings.
Treatment rates for mental disorders are particularly low in LMICs, where treatment gaps of more than 90 percent have been documented. Even where GBD data suggests lower prevalence rates in LMICs compared to HICs, this likely reflects underdetection rather than a genuinely lower burden. The proportion of DALYs caused by mental health disorders is higher in HICs than in LMICs, partly due to the greater burden of other health conditions in LMICs – but the absolute number of DALYs in LMICs is still higher than in HICs, due to their larger population size.
The funding gap
The disparity between where mental illness occurs and where resources flow is stark. Most people with mental health problems live in LMICs – around 80% – while 88% of spending to address these problems occurs in HICs. The majority of research funding in LMICs is directed towards communicable diseases, leaving mental health consistently under-resourced relative to the burden it generates. This misalignment between need and investment is one of the central problems the GBD data was designed to expose – and correct.
GBD 2010 highlighted a shift in burden from communicable to noncommunicable diseases and from YLLs to YLDs. Although communicable diseases remain a health priority in many LMICs, increasing life expectancies due to better reproductive health, childhood nutrition, and control of communicable diseases meant that more people in 2010 were living to ages where mental, neurological, and substance use disorders were most prevalent. This epidemiological transition means the mental health burden in LMICs is likely to grow – making the GBD’s regional data more urgent, not less.
The GBD’s lasting significance
The evolution of the GBD study from a single World Bank report to a continuously updated global database represents more than methodological progress. It represents a fundamental shift in how the world understands health. By introducing DALYs and YLDs, the GBD made it possible to see the full weight of conditions that kill slowly – or not at all – including depression, anxiety, bipolar disorder, and schizophrenia. By disaggregating data by region and income level, it exposed the structural inequalities that determine who gets diagnosed, treated, and counted.
The Institute for Health Metrics and Evaluation continues to refine and expand GBD estimates, with WHO and other agencies building on this foundation for global health monitoring. The WHO’s global DALY estimates – updated regularly and freely accessible – are a direct legacy of the original 1990 study. For mental health advocacy, few tools have been more powerful: numbers grounded in rigorous methodology, translated into a currency – lost years of healthy life – that governments and funders cannot easily dismiss.
What do you think? If health policy had continued to rely solely on mortality statistics, which mental health conditions do you think would still be most overlooked today – and why? And given that most people with mental illness live in LMICs but most mental health funding flows to HICs, what would genuinely equitable global mental health investment look like?
Leave a Reply